TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · IEX Real-Time Price · USD
4.40
+0.25 (6.02%)
Jun 2, 2023, 4:00 PM EDT - Market closed
TherapeuticsMD Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for TherapeuticsMD stock is $7.50, which predicts an increase of 70.45%. The lowest target is 5.00 and the highest is 10. On average, analysts rate TherapeuticsMD stock as a hold.
Analyst Consensus: Hold
* Price targets were last updated on Jan 11, 2023.
Analyst Ratings
The average analyst rating for TherapeuticsMD stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
7.34M
from 69.96M
Decreased by
-89.50%
Revenue Next Year
7.55M
from 7.34M
Increased by
2.78%
EPS This Year
0.19
from 11.96
Decreased by
-98.38%
EPS Next Year
0.13
from 0.19
Decreased by
-31.58%
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.10M | 49.65M | 64.87M | 2.57M | 69.96M | 7.34M | 7.55M | 7.65M | 7.75M | 7.85M |
| Revenue Growth | -4.04% | 208.38% | 30.67% | -96.03% | 2,619.12% | -89.50% | 2.78% | 1.35% | 1.33% | 1.32% |
| EPS | -29.50 | -36.00 | -33.50 | -21.66 | 11.96 | 0.19 | 0.13 | 0.13 | 0.14 | 0.14 |
| EPS Growth | - | - | - | - | - | -98.38% | -31.58% | - | 7.69% | - |
| No. Analysts | - | - | - | - | - | 3 | 3 | 3 | 3 | 3 |
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 7.6M | 7.8M | 7.9M | 8.0M | 8.1M |
| Avg | 7.3M | 7.5M | 7.7M | 7.8M | 7.9M |
| Low | 7.1M | 7.3M | 7.4M | 7.4M | 7.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -89.2%
| 5.8%
| 4.3%
| 4.3%
| 4.3%
|
| Avg | -89.5%
| 2.8%
| 1.4%
| 1.3%
| 1.3%
|
| Low | -89.9%
| -1.3%
| -2.6%
| -2.6%
| -2.7%
|
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 0.20 | 0.14 | 0.14 | 0.15 | 0.15 |
| Avg | 0.19 | 0.13 | 0.13 | 0.14 | 0.14 |
| Low | 0.19 | 0.13 | 0.13 | 0.14 | 0.14 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -98.3%
| -29.6%
| 2.9%
| 10.9%
| 2.9%
|
| Avg | -98.4%
| -31.6%
| - | 7.7%
| - |
| Low | -98.4%
| -34.3%
| -3.9%
| 3.5%
| -3.9%
|
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.